R. Schreiber

Di Cesare, F., Di Carlo, C., Di Cesare, L., Kottner, J., Zaragoza-Domingo, S., & Schreiber, R. (2026). Olfactory impairment in Huntington's disease: A systematic review and meta-analysis. Neuroscience Applied, 5, Article 107016. https://doi.org/10.1016/j.nsa.2026.107016

Magaraggia, I., Di Cesare, F., Alonso, J., Edgar, C. J., Heckman, P., Engler, J., Domingo, S. Z., Pani, L., & Schreiber, R. (2026). Application of the research domain criteria in early-phase clinical development of transdiagnostic neurotherapeutics: A multidisciplinary perspective. Neuroscience Applied, 5, Article 106996. https://doi.org/10.1016/j.nsa.2026.106996

Duller, S., Clarke, G., Herculano-Houzel, S., von Kanel, R., Kirsch, P., Landolt, H.-P., Naschold, B., Reber, S. O., Schreiber, R., Walter, M., & Slavich, G. M. (2025). Everyday stress-induced neurobehavioral dysregulation: therapeutic targets for management with Neurexan. Frontiers in Psychiatry, 16, Article 1577689. https://doi.org/10.3389/fpsyt.2025.1577689

van Veggel, L., Schepers, M., Tiane, A., Kumar, V., Willems, E., Rombaut, B., Noordijk, J., Vangansewinkel, T., Li, A., Wolfs, E., Ozcan, B., Nouboers, E., Moya, P. R., Sauer, D. B., Diliën, H., Hellings, N., Schreiber, R., & Vanmierlo, T. (2025). EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis. Biomedicine & Pharmacotherapy, 186, 117960. Article 117960. https://doi.org/10.1016/j.biopha.2025.117960

Magaraggia, I., Krauskopf, J., Ramaekers, J. G., You, Y., de Nijs, L., Briedé, J. J., & Schreiber, R. (2025). Harnessing brain-derived extracellular vesicles to support RDoC-based drug development. Neuroscience Applied, 4, Article 105406. https://doi.org/10.1016/j.nsa.2024.105406

van Veggel, L., Voets, A. M., Vanmierlo, T., & Schreiber, R. (2024). Insights from an academic endeavor into central nervous system drug discovery. Neural Regeneration Research, 20(6), 1717-1718. https://doi.org/10.4103/NRR.NRR-D-24-00340